Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of notch signaling in cancer

Molecular Therapy

Volumn 19, Issue 8, 2011, Pages 1538-1546

  Mamaeva, Veronika ^a   Rosenholm, Jessica M ^b   Bate Eya, Laurel Tabe ^a   Bergman, Lotta ^b   Peuhu, Emilia ^a,b   Duchanoy, Alain ^b   Fortelius, Lina E ^b   Landor, Sebastian ^a   Toivola, Diana M ^b   Lindén, Mika ^b,c   Sahlgren, Cecilia ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA SECRETASE INHIBITOR; MESOPOROUS SILICA NANOPARTICLE; NANOPARTICLE; NOTCH RECEPTOR; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CELL; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; STEM CELL;

EID: 79961032358     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.105     Document Type: Article

References (41)

1. Androutsellis-Theotokis, A, Leker, RR, Soldner, F, Hoeppner, DJ, Ravin, R, Poser, SW et al. (2006). Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442: 823-826. (Pubitemid 44258913)
2. Artavanis-Tsakonas, S, Rand, MD and Lake, RJ (1999). Notch signaling: cell fate control and signal integration in development. Science 284: 770-776. (Pubitemid 29291335)
3. Radtke, F and Raj, K (2003). The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3: 756-767. (Pubitemid 37328814)
4. Rizzo, P, Osipo, C, Foreman, K, Golde, T, Osborne, B and Miele, L (2008). Rational targeting of Notch signaling in cancer. Oncogene 27: 5124-5131.
5. Miele, L (2008). Rational targeting of Notch signaling in breast cancer. Expert Rev Anticancer Ther 8: 1197-1202.
6. Rizzo, P, Miao, H, D'Souza, G, Osipo, C, Song, LL, Yun, J et al. (2008). Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res 68: 5226-5235.
7. Ridgway, J, Zhang, G, Wu, Y, Stawicki, S, Liang, WC, Chanthery, Y et al. (2006). Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444: 1083-1087. (Pubitemid 46018529)
8. Kopan, R and Ilagan, MX (2009). The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137: 216-233.
9. Miele, L, Golde, T and Osborne, B (2006). Notch signaling in cancer. Curr Mol Med 6: 905-918. (Pubitemid 44883940)
10. Delaney, C, Heimfeld, S, Brashem-Stein, C, Voorhies, H, Manger, RL and Bernstein, ID (2010). Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 16: 232-236.
11. Moellering, RE, Cornejo, M, Davis, TN, Del Bianco, C, Aster, JC, Blacklow, SC et al. (2009). Direct inhibition of the NOTCH transcription factor complex. Nature 462: 182-188.
12. Wu, Y, Cain-Hom, C, Choy, L, Hagenbeek, TJ, de Leon, GP, Chen, Y et al. (2010). Therapeutic antibody targeting of individual Notch receptors. Nature 464: 1052-1057.
13. Yan, M, Callahan, CA, Beyer, JC, Allamneni, KP, Zhang, G, Ridgway, JB et al. (2010). Chronic DLL4 blockade induces vascular neoplasms. Nature 463: E6-E7.
14. van Es, JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, et al. (2005). Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435, 959-963. (Pubitemid 40896322)
15. Wong, GT, Manfra, D, Poulet, FM, Zhang, Q, Josien, H, Bara, T et al. (2004). Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem 279: 12876-12882. (Pubitemid 38445862)
16. Bray, SJ (2006). Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7: 678-689. (Pubitemid 44268213)
17. Cullion, K, Draheim, KM, Hermance, N, Tammam, J, Sharma, VM, Ware, C et al. (2009). Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood 113: 6172-6181.
18. Real, PJ, Tosello, V, Palomero, T, Castillo, M, Hernando, E, de Stanchina, E et al. (2009). Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med 15: 50-58.
19. Davis, ME, Chen, ZG and Shin, DM (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7: 771-782.
20. Ferrari, M (2005). Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5: 161-171. (Pubitemid 40314948)
21. Rosenholm, JM, Sahlgren, C and Linden, M (2010). Cancer-cell targeting and cell-specific delivery by mesoporous silica nanoparticles. J Mater Chem 20: 2707-2713.
22. Rosenholm, JM, Sahlgren, C and Lindén, M (2010). Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles-opportunities & challenges. Nanoscale 2: 1870-1883.
23. Rosenholm, JM, Meinander, A, Peuhu, E, Niemi, R, Eriksson, JE, Sahlgren, C et al. (2009). Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 3: 197-206.
24. Liong, M, Angelos, S, Choi, E, Patel, K, Stoddart, JF and Zink, JI (2009). Mesostructured multifunctional nanoparticles for imaging and drug delivery. J Mater Chem 19: 6251-6257.
25. Slowing, II, Vivero-Escoto, JL, Wu, CW and Lin, VS (2008). Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60: 1278-1288.
26. Rosenholm, JM, Peuhu, E, Bate-Eya, LT, Eriksson, JE, Sahlgren, C and Lindén, M (2010). Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. Small 6: 1234-1241.
27. Rosenholm, JM, Peuhu, E, Eriksson, JE, Sahlgren, C and Lindén, M (2009). Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems. Nano Lett 9: 3308-3311.
28. Liong, M, Lu, J, Kovochich, M, Xia, T, Ruehm, SG, Nel, AE et al. (2008). Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2: 889-896.
29. Efferson, CL, Winkelmann, CT, Ware, C, Sullivan, T, Giampaoli, S, Tammam, J et al. (2010). Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. Cancer Res 70: 2476-2484.
30. Pece, S, Serresi, M, Santolini, E, Capra, M, Hulleman, E, Galimberti, V et al. (2004). Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 167: 215-221. (Pubitemid 39435065)
31. Sahlgren, C, Gustafsson, MV, Jin, S, Poellinger, L and Lendahl, U (2008). Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 105: 6392-6397. (Pubitemid 351758356)
32. Lu, J, Liong, M, Li, Z, Zink, JI and Tamanoi, F (2010). Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6: 1794-1805.
33. Fre, S, Pallavi, SK, Huyghe, M, Laé, M, Janssen, KP, Robine, S et al. (2009). Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc Natl Acad Sci USA 106: 6309-6314.
34. Fre, S, Huyghe, M, Mourikis, P, Robine, S, Louvard, D and Artavanis-Tsakonas, S (2005). Notch signals control the fate of immature progenitor cells in the intestine. Nature 435: 964-968. (Pubitemid 40896323)
35. Dong, Y, Li, A, Wang, J, Weber, JD and Michel, LS (2010). Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer. Cancer Res 70: 5465-5474.
36. Maeda, H (2010). Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 21: 797-802.
37. Tsai, C-P, Chen, C-Y, Hung, Y, Chang, F-H and Mou, C-Y (2009). Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells. J Mater Chem 19: 5737-5743.
38. Zhu, C-L, Song, X-Y, Zhou, W-H, Yang, H-H, Wen, Y-H and Wang X-R (2009). An efficient cell-targeting and intracellular controlled-release drug delivery system based on MSN-PEM-aptamer conjugates. J Mater Chem 41: 7765-7770.
39. Burns, AA, Vider, J, Ow, H, Herz, E, Penate-Medina, O, Baumgart, M et al. (2009). Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 9: 442-448.
40. Souris, JS, Lee, CH, Cheng, SH, Chen, CT, Yang, CS, Ho, JA et al. (2010). Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials 31: 5564-5574.
41. Nakamura, T, Yamada, Y and Yano, K (2007). Direct synthesis of monodispersed thiolfunctionalized nanoporous silica spheres and their application to a colloidal crystal embedded with gold nanoparticles. J Mater Chem 17: 3726-3732. (Pubitemid 47330704)